Table 2 Comparison of annual diabetes costs per patient in Spain
From: Costs, outcomes and challenges for diabetes care in Spain
| Â | Mata et al. (CODE 2) | Oliva et al. | Ballesta et al. | Lopez Bastida et al. |
|---|---|---|---|---|
Publication year | 2002 | 2004 | 2006 | 2002 |
Reference year | 1998 | 2002 | 1999 | 1998 |
Type of study | National, observational, prevalence and bottom-up approach. | National, prevalence and top-down approach. | Regional, observational, prevalence and bottom-up approach. | Regional, prevalence and top-down approach. |
Type of costs | Direct health care costs | Direct health care costs | Direct health care costs and productivity losses (human capital) | Direct health care costs and productivity losses (human capital) |
Sources of resources used | Primary data. | Primary and secondary data. | Primary data. | Primary data. |
Diabetes Type | Type II | Type I & II | Type II | Type I & II |
Age | 30-89 years | 18+ years | 14+ years | 0-99 years |
Total costs | €1305 | €1290-1476 | €4278 | €758 |
Direct: €2504 | Direct: €470 | |||
Productivity €1774 | Productivity: €288 | |||
Drug costs | €554 | €636 | €851 | €179 |
Hospitalization costs | €417 | €512 | €1005 | €183 |
% inpatient costs | 59.8% | 37% | 39% | 38% |
% outpatient costs | 18.5% | 17% | 28% | 23% |
% drug costs | 21.7% | 46% | 33% | 39% |